60 Degrees Pharmaceuticals (SXTP) Preferred Dividend Payments (2023 - 2025)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Preferred Dividend Payments of $118158.0 for Q1 2025, little changed year-over-year from $117881.0 in Q1 2024, and down 9.78% quarter-over-quarter from $130968.0 in Q4 2024.
60 Degrees Pharmaceuticals (SXTP) Preferred Dividend Payments (2023 - 2025) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Preferred Dividend Payments for 3 consecutive years, with $118158.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Preferred Dividend Payments changed 0.23% year-over-year to $118158.0; the TTM figure through Mar 2025 stood at $483578.0 (changed N/A YoY), while the FY2024 annual figure was $483301.0, up 118.97% from the prior year.
- Preferred Dividend Payments declined to $118158.0 in Q1 2025 per SXTP's latest filing, from $130968.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $130968.0 in Q4 2024 and bottomed at $101538.0 in Q3 2023.
- Historically, Preferred Dividend Payments has averaged $117453.3 across 3 years, with a median of $117881.0 in 2024.
- Annual changes were most pronounced in 2024 — Preferred Dividend Payments advanced 14.81% — and 2025, when it grew 0.23%.
- 60 Degrees Pharmaceuticals' Preferred Dividend Payments stood at $119176.0 in 2023, then grew by 9.89% to $130968.0 in 2024, then retreated by 9.78% to $118158.0 in 2025.
- Business Quant data shows SXTP's Preferred Dividend Payments at $118158.0 in Q1 2025, $130968.0 in Q4 2024, and $116571.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 118,158.00 |
| Dec 31, 2024 | 130,968.00 |
| Sep 30, 2024 | 116,571.00 |
| Jun 30, 2024 | 117,881.00 |
| Mar 31, 2024 | 117,881.00 |
| Dec 31, 2023 | 119,176.00 |
| Sep 30, 2023 | 101,538.00 |